Driving Global Innovation in
TFT Semiconductor Applications

Novel Optoelectronics Business

LinkZill pioneered a series of standardized portable product lines based on its core TFT semiconductor technology, including display, sensing, and measurement series. We provide one-stop services ranging from TFT chips, systems, and processes to technical support for various research scenarios such as photodetection, novel light-emitting displays, and sensor electrical signal measurement. At the same time, LinkZill continuously offers TFT-customized design and system customization services for customers worldwide.

Life Sciences Business

LinkZill empowers life sciences with TFT semiconductor technology, creating the world’s first TFT-based DNA synthesizer alongside superior oligo microarrays and oligo pools. These products form a comprehensive business ecosystem spanning end-user devices, mass-produced chip consumables, and synthesis products, providing efficient synthesis solutions for companies and research institutions engaged in synthetic biology, high-throughput omics technologies, innovative drug discovery, medical diagnostics, and molecular breeding. Leveraging its proprietary TFT biochip platform, LinkZill aims to build fully integrated next-generation life science tools.

Highlights

Highlights

About LinkZill

300

+

Global Customers

20

+

Countries and Regions Covered

200

+

Papers Published Using LinkZill’s Products

40%

+

Overseas Revenue Share

LinkZill Global Layout

UK Subsidiary

The Bradfield Centre, 184 Cambridge Science Park, Milton Road, Cambridge CB4 OGA, UK

China Headquarters

Block B1, South Area, 181 Wuchang Blvd, Yuhang District, Hangzhou, Zhejiang Province, China

LinkZill Global Layout

UK Subsidiary

The Bradfield Centre, 184 Cambridge Science Park, Milton Road, Cambridge CB4 OGA, UK

China Headquarters

Block B1, South Area, 181 Wuchang Blvd, Yuhang District, Hangzhou, Zhejiang Province, China

Upcoming Exhibitions

The International Genetically Engineered Machine Competition (iGEM) 2025

LinkZill will showcase the world’s first
TFT-based oligonucleotide microarray synthesizer

28–31 October, 2025

Paris Convention Centre

Dr. Kang Kang

Partner & CBio

Dr. Kang received his Ph.D. in Bioinformatics and Systems Biology from the University of Hong Kong in 2018, then became a scientific co-worker of the Leibniz Association (Leibniz-HKI) and a visiting scientist at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark. He was a scientist at BGI-Shenzhen and co-founded the synthetic biology research group. He was a senior bioinformatics engineer and brand advisor at WeGene. In 2021, Kang joined Biosysen Limited as a co-founder and served as Chief Informatics Scientist. He is also an advisor and author of the biotech media "Regenesis". He has been dedicated to the R&D and industrialization of OMICs technologies, high-throughput technologies, and synthetic biology for over 10 years. He joined LinkZill in March 2023, responsible for semiconductor life science tools and product planning.

康康   博士

合伙人兼首席生物信息官

博士毕业于香港大学生物信息和系统生物学专业,后任德国莱布尼茨协会科学合作者、丹麦科技大学诺和诺德生物可持续研究中心访问科学家。曾先后担任华大基因科学家,参与创立了华大基因合成生物学研究方向;微基因资深生物信息工程师、品牌顾问;倍生生物联合创始人兼首席信息科学家。他专注于合成生物学、组学和高通量技术10余年,同时也是生物技术领域颇具影响力的「行业KOL」。2023年3月加入领挚科技,负责半导体生命科学工具方向与产品规划。